Dobutamine Hydrochloride 5% Dextrose 2mg/mL (200mcg/mL) Solution for Injection IV Philippines - English - FDA (Food And Drug Administration)

dobutamine hydrochloride 5% dextrose 2mg/ml (200mcg/ml) solution for injection iv

baxter healthcare phils inc - dobutamine hydrochloride 5% dextrose - solution for injection iv - 2mg/ml (200mcg/ml)

NOXAFIL posaconazole 300 mg/16.7 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

noxafil posaconazole 300 mg/16.7 ml concentrated injection vial

merck sharp & dohme (australia) pty ltd - posaconazole, quantity: 300 mg - injection, concentrated - excipient ingredients: sulfobutyl betadex sodium; disodium edetate; hydrochloric acid; sodium hydroxide; water for injections - noxafil (posaconazole) concentrated injection is indicated for use in the treatment of the following invasive fungal infections in adults: invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy. fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy. noxafil is also indicated for the: prophylaxis of invasive fungal infections among adults, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.

COSDOR dorzolamide (as hydrochloride) 20 mg/mL and timolol (as maleate) 5 mg/mL eye drop bottle Australia - English - Department of Health (Therapeutic Goods Administration)

cosdor dorzolamide (as hydrochloride) 20 mg/ml and timolol (as maleate) 5 mg/ml eye drop bottle

viatris pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops - excipient ingredients: mannitol; benzalkonium chloride; hyetellose; water for injections; sodium citrate dihydrate; sodium hydroxide - cosdor is indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.

COSOPT PRESERVATIVE-FREE dorzolamide (as hydrochloride) 20mg/mL and timolol (as maleate) 5mg/mL single dose eye drop ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

cosopt preservative-free dorzolamide (as hydrochloride) 20mg/ml and timolol (as maleate) 5mg/ml single dose eye drop ampoule

mundipharma pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops, solution - excipient ingredients: mannitol; sodium hydroxide; water for injections; hyetellose; sodium citrate dihydrate - cosopt preservative free is indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concominant therapy is appropriate.

DILTIAZEM AN diltiazem hydrochloride 60mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

diltiazem an diltiazem hydrochloride 60mg tablet blister pack

arrotex pharmaceuticals pty ltd - diltiazem hydrochloride, quantity: 60 mg - tablet, film coated - excipient ingredients: lactose monohydrate; hydrogenated castor oil; aluminium hydroxide; methacrylic acid copolymer; purified talc; magnesium stearate; titanium dioxide; indigo carmine; methylcellulose; macrogol 400 - moderate to severe angina pectoris due to atherosclerotic coronary artery disease or coronary artery spasm (vasospastic angina).